| UniProt ID | PHLP2_HUMAN | |
|---|---|---|
| UniProt AC | Q6ZVD8 | |
| Protein Name | PH domain leucine-rich repeat-containing protein phosphatase 2 | |
| Gene Name | PHLPP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1323 | |
| Subcellular Localization |
Cytoplasm. Membrane Peripheral membrane protein. Nucleus. In colorectal cancer tissue, expression is concentrated in the cytoplasm and nucleus. |
|
| Protein Description | Protein phosphatase involved in regulation of Akt and PKC signaling. Mediates dephosphorylation in the C-terminal domain hydrophobic motif of members of the AGC Ser/Thr protein kinase family; specifically acts on 'Ser-473' of AKT1, 'Ser-660' of PRKCB isoform beta-II and 'Ser-657' of PRKCA. Akt regulates the balance between cell survival and apoptosis through a cascade that primarily alters the function of transcription factors that regulate pro- and antiapoptotic genes. Dephosphorylation of 'Ser-473' of Akt triggers apoptosis and decreases cell proliferation. Also controls the phosphorylation of AKT3. Dephosphorylates STK4 on 'Thr-387' leading to STK4 activation and apoptosis. [PubMed: 20513427 Dephosphorylates RPS6KB1 and is involved in regulation of cap-dependent translation] | |
| Protein Sequence | MKRNGSRNCLNRRSRFGSRERDWLREDVKRGCVYLYGADTTTATTTTTTSSSSSSSSSSSDLHLVLCTVETPASEICAGEGRESLYLQLHGDLVRRLEPTERPLQIVYDYLSRLGFDDPVRIQEEATNPDLGCMIRFYGEKPCHMDRLDRILLSGIYNVRKGKTQLHKWAERLVVLCGTCLIVSSVKDCQTGKMHILPLVGGKIEEVKRRQYSLAFSSAGAQAQTYHVSFETLAEYQRWQRQASKVVSQRISTVDLSCYSLEEVPEHLFYSQDITYLNLRHNFMQLERPGGLDTLYKFSQLKGLNLSHNKLGLFPILLCEISTLTELNLSCNGFHDLPSQIGNLLNLQTLCLDGNFLTTLPEELGNLQQLSSLGISFNNFSQIPEVYEKLTMLDRVVMAGNCLEVLNLGVLNRMNHIKHVDLRMNHLKTMVIENLEGNKHITHVDLRDNRLTDLDLSSLCSLEQLHCGRNQLRELTLSGFSLRTLYASSNRLTAVNVYPVPSLLTFLDLSRNLLECVPDWACEAKKIEVLDVSYNLLTEVPVRILSSLSLRKLMLGHNHVQNLPTLVEHIPLEVLDLQHNALTRLPDTLFSKALNLRYLNASANSLESLPSACTGEESLSMLQLLYLTNNLLTDQCIPVLVGHLHLRILHLANNQLQTFPASKLNKLEQLEELNLSGNKLKTIPTTIANCKRLHTLVAHSNNISIFPEILQLPQIQFVDLSCNDLTEILIPEALPATLQDLDLTGNTNLVLEHKTLDIFSHITTLKIDQKPLPTTDSTVTSTFWSHGLAEMAGQRNKLCVSALAMDSFAEGVGAVYGMFDGDRNEELPRLLQCTMADVLLEEVQQSTNDTVFMANTFLVSHRKLGMAGQKLGSSALLCYIRPDTADPASSFSLTVANVGTCQAVLCRGGKPVPLSKVFSLEQDPEEAQRVKDQKAIITEDNKVNGVTCCTRMLGCTYLYPWILPKPHISSTPLTIQDELLILGNKALWEHLSYTEAVNAVRHVQDPLAAAKKLCTLAQSYGCQDNVGAMVVYLNIGEEGCTCEMNGLTLPGPVGFASTTTIKDAPKPATPSSSSGIASEFSSEMSTSEVSSEVGSTASDEHNAGGLDTALLPRPERRCSLHPTPTSGLFQRQPSSATFSSNQSDNGLDSDDDQPVEGVITNGSKVEVEVDIHCCRGRDLENSPPLIESSPTLCSEEHARGSCFGIRRQNSVNSGMLLPMSKDRMELQKSPSTSCLYGKKLSNGSIVPLEDSLNLIEVATEVPKRKTGYFAAPTQMEPEDQFVVPHDLEEEVKEQMKQHQDSRLEPEPHEEDRTEPPEEFDTAL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Phosphorylation | NRRSRFGSRERDWLR CCCCCCCCHHHHHHH | 28.40 | 24719451 | |
| 52 | Phosphorylation | TTTTTSSSSSSSSSS EEEECCCCCCCCCCC | 33.72 | - | |
| 53 | Phosphorylation | TTTTSSSSSSSSSSS EEECCCCCCCCCCCC | 35.87 | - | |
| 54 | Phosphorylation | TTTSSSSSSSSSSSD EECCCCCCCCCCCCC | 35.87 | - | |
| 55 | Phosphorylation | TTSSSSSSSSSSSDL ECCCCCCCCCCCCCE | 35.87 | - | |
| 141 | Ubiquitination | MIRFYGEKPCHMDRL EEEEECCCCCCHHHH | 48.89 | - | |
| 302 | Ubiquitination | LYKFSQLKGLNLSHN HHHHHHCCCCCCCCC | 54.43 | 29967540 | |
| 481 | Phosphorylation | ELTLSGFSLRTLYAS HHHHCCCCHHHHHHC | 22.07 | 24719451 | |
| 547 | Phosphorylation | VPVRILSSLSLRKLM CCHHHHHHHCHHHHH | 20.66 | 17081983 | |
| 549 | Phosphorylation | VRILSSLSLRKLMLG HHHHHHHCHHHHHCC | 28.24 | 17081983 | |
| 591 | Phosphorylation | RLPDTLFSKALNLRY CCCHHHHHHHHCHHH | 21.82 | 24719451 | |
| 592 | Ubiquitination | LPDTLFSKALNLRYL CCHHHHHHHHCHHHH | 49.94 | - | |
| 612 | Ubiquitination | SLESLPSACTGEESL CHHCCCCCCCCHHHH | 7.92 | 29967540 | |
| 663 | Ubiquitination | LQTFPASKLNKLEQL CCCCCHHHCHHHHHH | 59.18 | 29967540 | |
| 666 | Ubiquitination | FPASKLNKLEQLEEL CCHHHCHHHHHHHHC | 64.93 | 29967540 | |
| 679 | Ubiquitination | ELNLSGNKLKTIPTT HCCCCCCCCCCCCHH | 55.69 | 29967540 | |
| 691 | Ubiquitination | PTTIANCKRLHTLVA CHHHHHHHHHHHHHH | 58.77 | - | |
| 1066 | Methylation | TTIKDAPKPATPSSS CCCCCCCCCCCCCCC | 49.34 | - | |
| 1119 | Phosphorylation | PRPERRCSLHPTPTS CCCCCCCCCCCCCCC | 28.09 | 28152594 | |
| 1123 | Phosphorylation | RRCSLHPTPTSGLFQ CCCCCCCCCCCCCCC | 28.57 | 28152594 | |
| 1125 | Phosphorylation | CSLHPTPTSGLFQRQ CCCCCCCCCCCCCCC | 37.59 | 27080861 | |
| 1126 | Phosphorylation | SLHPTPTSGLFQRQP CCCCCCCCCCCCCCC | 34.40 | 27080861 | |
| 1143 | Phosphorylation | ATFSSNQSDNGLDSD CEECCCCCCCCCCCC | 36.98 | 32645325 | |
| 1149 | Phosphorylation | QSDNGLDSDDDQPVE CCCCCCCCCCCCCCE | 48.24 | - | |
| 1182 | Phosphorylation | RGRDLENSPPLIESS CCCCCCCCCCCCCCC | 20.65 | 28985074 | |
| 1188 | Phosphorylation | NSPPLIESSPTLCSE CCCCCCCCCCCCCCC | 34.32 | 27050516 | |
| 1189 | Phosphorylation | SPPLIESSPTLCSEE CCCCCCCCCCCCCCC | 14.76 | 29978859 | |
| 1191 | Phosphorylation | PLIESSPTLCSEEHA CCCCCCCCCCCCCHH | 42.20 | 29978859 | |
| 1194 | Phosphorylation | ESSPTLCSEEHARGS CCCCCCCCCCHHCCC | 49.48 | 29978859 | |
| 1210 | Phosphorylation | FGIRRQNSVNSGMLL CCCCCCCCCCCCCEE | 17.84 | 22617229 | |
| 1213 | Phosphorylation | RRQNSVNSGMLLPMS CCCCCCCCCCEECCC | 24.35 | 28450419 | |
| 1220 | Phosphorylation | SGMLLPMSKDRMELQ CCCEECCCCCCHHHC | 29.48 | 29083192 | |
| 1229 | Phosphorylation | DRMELQKSPSTSCLY CCHHHCCCCCCCHHC | 15.89 | 25159151 | |
| 1231 | Phosphorylation | MELQKSPSTSCLYGK HHHCCCCCCCHHCCC | 39.79 | 25849741 | |
| 1232 | Phosphorylation | ELQKSPSTSCLYGKK HHCCCCCCCHHCCCC | 27.18 | 30576142 | |
| 1233 | Phosphorylation | LQKSPSTSCLYGKKL HCCCCCCCHHCCCCC | 13.38 | 28985074 | |
| 1236 | Phosphorylation | SPSTSCLYGKKLSNG CCCCCHHCCCCCCCC | 31.09 | 29083192 | |
| 1241 | Phosphorylation | CLYGKKLSNGSIVPL HHCCCCCCCCCEEEH | 48.28 | 29496963 | |
| 1244 | Phosphorylation | GKKLSNGSIVPLEDS CCCCCCCCEEEHHHH | 25.35 | 29496963 | |
| 1251 | Phosphorylation | SIVPLEDSLNLIEVA CEEEHHHHHHHHHHH | 15.13 | 28450419 | |
| 1259 | Phosphorylation | LNLIEVATEVPKRKT HHHHHHHHCCCCCCC | 42.57 | 23090842 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PHLP2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PHLP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PHLP2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RADI_HUMAN | RDX | physical | 19615732 | |
| UBP1_HUMAN | USP1 | physical | 19615732 | |
| EZRI_HUMAN | EZR | physical | 19615732 | |
| NHRF2_HUMAN | SLC9A3R2 | physical | 19615732 | |
| NHRF1_HUMAN | SLC9A3R1 | physical | 19615732 | |
| VAT1_HUMAN | VAT1 | physical | 19615732 | |
| WDR48_HUMAN | WDR48 | physical | 19615732 | |
| UBP46_HUMAN | USP46 | physical | 19615732 | |
| SNX27_HUMAN | SNX27 | physical | 19615732 | |
| WDR20_HUMAN | WDR20 | physical | 19615732 | |
| UBP12_HUMAN | USP12 | physical | 19615732 | |
| UBP12_HUMAN | USP12 | physical | 25216524 | |
| WDR48_HUMAN | WDR48 | physical | 25216524 | |
| WDR20_HUMAN | WDR20 | physical | 25216524 | |
| NHRF1_HUMAN | SLC9A3R1 | physical | 21804599 | |
| DMWD_HUMAN | DMWD | physical | 27880917 | |
| NHRF1_HUMAN | SLC9A3R1 | physical | 27880917 | |
| NHRF2_HUMAN | SLC9A3R2 | physical | 27880917 | |
| SNX27_HUMAN | SNX27 | physical | 27880917 | |
| SGT1_HUMAN | SUGT1 | physical | 27880917 | |
| UBP1_HUMAN | USP1 | physical | 27880917 | |
| UBP12_HUMAN | USP12 | physical | 27880917 | |
| UBP46_HUMAN | USP46 | physical | 27880917 | |
| VAT1_HUMAN | VAT1 | physical | 27880917 | |
| WDR20_HUMAN | WDR20 | physical | 27880917 | |
| WDR48_HUMAN | WDR48 | physical | 27880917 | |
| CUL3_HUMAN | CUL3 | physical | 28859855 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...